FLT4 Antikörper (C-Term, Cytoplasmic Domain)
Kurzübersicht für FLT4 Antikörper (C-Term, Cytoplasmic Domain) (ABIN2385250)
Target
Alle FLT4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term, Cytoplasmic Domain
-
Kreuzreaktivität
- Maus
-
Kreuzreaktivität (Details)
- Calculated cross reactivity: Mo
-
Produktmerkmale
- VEGFR3 (Vascular Endothelial Growth Factor Receptor 3, VEGFR-3, Fms-like Tyrosine Kinase 4, FLT-4, Tyrosine-protein Kinase Receptor FLT4, FLT4)
-
Aufreinigung
- Purified by immunoaffinity chromatography.
-
Immunogen
- Synthetic peptide corresponding to 20aa near the C-terminal, cytoplasmic domain of mouse VEGFR3, conjugated to KLH. Species Sequence Homology: rat, 85%, human, 73%.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working conditions should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Reconstitute with 100 μL sterile PBS.
-
Buffer
- Supplied as a lyophilized powder from PBS, 0.1 % BSA.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C
-
-
- FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))
-
Andere Bezeichnung
- VEGFR3
-
Pathways
- RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling
Target
-